Skip to main content
. 2023 Jul 22;25:125. doi: 10.1186/s13075-023-03116-5

Fig. 4.

Fig. 4

Correlation between anti-Jo-1 concentration changes and disease activity evolution (global (A), muscular (B), pulmonary (C), cutaneous (D), articular (E), cardiological (F), gastrointestinal (G), constitutional (H) disease activity) in each patient (n = 29) during the follow-up